Inici › Malaltia de Crohn › Texas › Lubbock
Assaigs clínics de Malaltia de Crohn a Lubbock, TX
10 estudis de Malaltia de Crohn busquen participants en centres de Lubbock i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
ReclutantFase 3
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
ReclutantFase 3
- Caprock Gastro Research ( Site 5077), Lubbock
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
ReclutantFase 2
- GI Alliance - Lubbock /ID# 283920, Lubbock
- Caprock Gastro Research - Lubbock /ID# 283921, Lubbock
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
ReclutantFase 4
- West Texas Research Institute, Lubbock
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
ReclutantFase 2
- Caprock Gastro Research - Lubbock /ID# 265541, Lubbock
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 3
- Lubbock Gastroenterology, Lubbock
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 3
- GI Alliance - Lubbock-Site Number: 8400092, Lubbock
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 3
- GI Alliance - Lubbock-Site Number: 8400092, Lubbock
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
ReclutantFase 4
- Texas Digestive Disease Consultants Lubbock, Lubbock
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
ReclutantFase 2
- Mirador Therapeutics Selected Site, Lubbock
Assaigs de Malaltia de Crohn en altres ciutats
- New York City, NY35 estudis
- Cleveland, OH19 estudis
- St. Louis, MO19 estudis
- Boston, MA19 estudis
- Miami, FL19 estudis
- Orlando, FL17 estudis
- Houston, TX17 estudis
- Atlanta, GA17 estudis
- Tyler, TX16 estudis
- San Diego, CA15 estudis
- San Antonio, TX15 estudis
- Los Angeles, CA15 estudis
Altres estudis a Lubbock
- Colitis ulcerosa9 estudis
- Càncer de mama6 estudis
- Càncer de pulmó de cèl·lules no petites4 estudis
- Artritis psoriàsica3 estudis
- Ictus3 estudis
- Sobrepès3 estudis
- Obesitat3 estudis
- Malaltia inflamatòria intestinal3 estudis
- Limfoma de Burkitt3 estudis
- Mieloma múltiple3 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.